This subgroup focuses on identifying genetic markers and disease patterns to better understand complex conditions such as cancer, cardiovascular disease, and diabetes. Leveraging genomic and proteomic data from initiatives like the Qatar Genome Project (QGP) and Qatar Biobank, researchers uncover population-specific characteristics that inform precision medicine strategies. The group’s findings have been published in leading journals, including Nature Methods, Nature Communications, and Lancet Oncology.